Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Cancer Research
|
February 10, 2000
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
B S Reddy, Y Hirose, R Lubet, et al.
Cancer
|
July 1, 1980
Prognostic significance of serum lactate dehydrogenase in malignant lymphoma
R J Schneider, K Seibert, S Passe, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors
J S Carter, D J Rogier, M J Graneto, et al.
Molecular Carcinogenesis
|
August 17, 1999
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
S M Fischer, H H Lo, G B Gordon, et al.
The Biochemical Journal
|
January 15, 1995
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
J K Gierse, S D Hauser, D P Creely, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages
J L Masferrer, S T Reddy, B S Zweifel, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
D Salvemini, P T Manning, B S Zweifel, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase
K Seibert, J Masferrer, Y Zhang, et al.
The Journal of Experimental Medicine
|
September 1, 1996
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
J P Portanova, Y Zhang, G D Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
J L Masferrer, B S Zweifel, P T Manning, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Cancer Research
|
February 10, 2000
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
B S Reddy, Y Hirose, R Lubet, et al.
Cancer
|
July 1, 1980
Prognostic significance of serum lactate dehydrogenase in malignant lymphoma
R J Schneider, K Seibert, S Passe, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors
J S Carter, D J Rogier, M J Graneto, et al.
Molecular Carcinogenesis
|
August 17, 1999
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
S M Fischer, H H Lo, G B Gordon, et al.
The Biochemical Journal
|
January 15, 1995
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
J K Gierse, S D Hauser, D P Creely, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages
J L Masferrer, S T Reddy, B S Zweifel, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
D Salvemini, P T Manning, B S Zweifel, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase
K Seibert, J Masferrer, Y Zhang, et al.
The Journal of Experimental Medicine
|
September 1, 1996
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
J P Portanova, Y Zhang, G D Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
J L Masferrer, B S Zweifel, P T Manning, et al.
Page
of 9